DC-SIGN (CT) Blocking Peptide
DC-SIGN (CT) Blocking Peptide
Product No.: D287
[product_table name="All Top" skus="D287"]
- -
- -
| Target DC-SIGN Product Type Blocking Peptide |
- -
- -
| Select Product Size | Qty Max: Min: 1 Step: 1 $110.00 |
- -
- -
Antibody DetailsProduct DetailsReactive Species Human Product Concentration 0.2 mg/ml Amino Acid Location This peptide sequence is located at amino acids 384 to 404 of Human DC-SIGN protein. Formulation This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide. Storage and Handling Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. Country of Origin USA Shipping Next Day Ambient Amino Acid Sequence 21 amino acids near the carboxy terminus of human DC-SIGN. Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionBackground DC-SIGN peptide is applicable as a control peptide for blocking antibody binding in Western blotting. References & Citations1. Kawai T, Nomura F, Hoshino K, Copeland NG, Gilbert DJ, Jenkins NA, Akira S. Death-associated protein kinase 2 is a new calcium/calmodulin-dependent protein kinase that signals apoptosis through its catalytic activity. Oncogene 1999;18(23):3471-80
2. Inbal B, Shani G, Cohen O, Kissil JL, Kimchi A. Death-associated protein kinase-related protein 1, a novel serine/threonine kinase involved in apoptosis. Mol Cell Biol 2000;20(3):1044-54 (WD0101)
3. Geijtenbeek TB, Kwon DS, Torensma R, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 2000;100:587-97. |
Related Products
- -
- -
Prod No. | Description |
|---|---|
| D286 | |
| D288 | |
| D287 | |
| D289 | |
| D367 | |
| D368 |
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
